Hydroxocobalamin-attributed Risk of Oxalate Nephropathy: Evidence is Not Sufficient to Change the Recommended Management of Cyanide Toxicity by Fire Smoke Inhalation

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2016 Apr 15

PMID 27075761

Citations 2

Authors

Bruno Megarbane

Affiliations

Soon will be listed here.

Citing Articles

Hydroxocobalamin-induced oxalate nephropathy after smoke inhalation.

Hamdini L, Ydee A, Larsen S, Gibier J, Azar R, Petit V J Nephrol. 2023; 36(5):1443-1445.

PMID: 36853498 DOI: 10.1007/s40620-023-01592-1.

Outcomes after the administration of hydroxocobalamin.

Pruskowski K, Britton G, Cancio L Int J Burns Trauma. 2020; 10(5):231-236.

PMID: 33224611 PMC: 7675202.

References

Borron S, Stonerook M, Reid F . Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol (Phila). 2006; 44 Suppl 1:5-15. DOI: 10.1080/15563650600811672. View

Borron S, Baud F, Barriot P, Imbert M, Bismuth C . Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007; 49(6):794-801, 801.e1-2. DOI: 10.1016/j.annemergmed.2007.01.026. View

Thompson J, Marrs T . Hydroxocobalamin in cyanide poisoning. Clin Toxicol (Phila). 2012; 50(10):875-85. DOI: 10.3109/15563650.2012.742197. View

Legrand M, Michel T, Daudon M, Benyamina M, Ferry A, Soussi S . Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients. Intensive Care Med. 2016; 42(6):1080-1. DOI: 10.1007/s00134-016-4252-4. View